It's always been stated that there will be a 12 month assessment...

It's always been stated that there will be a 12 month assessment period or the results, after the enrolment of the final patient. On a couple of occasions PNV have said that the final patient will be enrolled in May. I suspect @hottod is correct and the time line may have slipped a month or two. In any case we must be very close to 120 right now.

I still draw peoples attention to this header on the paper that was recently presented at the Macquarie Conference. This has not been explained in any way to my knowledge.




I'm speculating here. But could it be that IQVIA have been engaged to help fast track FDA/BARDA approval of the trial via "Real World Evidence". This has been alluded to on a number of occasions by both Swami and DW. Could there possibly be a pending announcement this September? I'll certainly be asking the question at the upcoming full year results presentation. If there has not been any clarification prior to then.

https://www.iqvia.com/solutions/real-world-evidence